🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed Phase IIB/III randomized, double-blind, placebo-controlled tri...
Status
Active Not Recruiting
Location
Institut Cancerologie de L'Ouest (ICO)
Start Date
2019-12-01
Trial ID
NCT04250922
The MONET BRIDGE study is designed to assess the use of cangrelor as a plat...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06-01
Trial ID
NCT03862651
Treatments Being Tested
This is a randomized, open-label, multi-center, global, Phase III study to ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-06-01
Trial ID
NCT03164616
The main goals of this study are to learn about the safety of sacituzumab t...
Status
Recruiting
Location
University of Alabama at Birmingham ( Site 0006)
Start Date
2025-04-09
Trial ID
NCT06824467
The purpose of this clinical trial is to compare drug combinations to learn...
Status
Recruiting
Location
University of Alabama Birmingham
Start Date
2025-07-25
Trial ID
NCT06859424
Treatments Being Tested
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + r...
Status
Recruiting
Location
Research Site
Start Date
2025-03-27
Trial ID
NCT06989112
Treatments Being Tested
In the China extension study, Chinese participants with programmed cell dea...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-01
Trial ID
NCT03850444
Treatments Being Tested
This study is open to patients with a type of cancer called melanoma. Patie...
Status
Active Not Recruiting
Location
University Health Network- Princess Margaret Cancer Centre
Start Date
2024-06-24
Trial ID
NCT06377111
Treatments Being Tested
An interventional, non-randomised study to assess the risk of progression a...
Status
Recruiting
Location
Cork University Hospital
Start Date
2023-08-28
Trial ID
NCT05866757
Treatments Being Tested
A pilot study to assess the risk of progression after stopping post-autolog...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2021-12-31
Trial ID
NCT05192122
Treatments Being Tested